Genesis DNA Overview

  • Founded
  • 2015

  • Status
  • Out of Business

  • Employees
  • 3

  • Latest Deal Type
  • Out of Business

Genesis DNA General Information


Developer of a genome technology intended to make gene synthesis rapid, inexpensive, and sequence invariant. The company develops a technology that helps to convert digital text into physical DNA, thereby circumventing the cost, turnaround time, and sequence limiting factors of existing synthesis methods.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • Cambridge, MA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genesis DNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-May-2017 00000 Completed Out of Business
4. Early Stage VC 00000 Completed Startup
3. Accelerator/Incubator 01-Jan-2016 00000 Completed Startup
2. Accelerator/Incubator 12-Sep-2015 $20K $250K Completed Startup
1. Accelerator/Incubator 10-Sep-2015 $250K $250K 00.000 Completed Startup
To view Genesis DNA’s complete valuation and funding history, request access »

Genesis DNA Patents

Genesis DNA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160376584-A1 Method and apparatus for dual solid phase nucleic acid synthesis Inactive 29-Jun-2015 00000000000

Genesis DNA Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial